Patents
Patents for C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
06/2006
06/22/2006WO2006065277A2 Heterocyclic aspartyl protease inhibitors
06/22/2006CA2591033A1 Heterocyclic aspartyl protease inhibitors
06/15/2006WO2006061417A2 Macrocyclic quinazole derivatives and their use as mtki
06/15/2006WO2006061415A1 2,4 (4,6) pyrimidine derivatives
06/15/2006CA2588764A1 Macrocyclic quinazole derivatives and their use as mtki
06/15/2006CA2588761A1 2,4(4,6)pyrimidine derivatives
06/13/2006US7060817 Sulfonamide anions as catalysts for NCO oligomerization
06/08/2006WO2005107464A3 Compounds and compositions as cathepsin s inhibitors
06/07/2006EP1663960A2 Amidines and derivatives thereof and pharmaceutical compositions containing them
06/07/2006EP0934065B1 Novel cryptophycin derivatives as anti-neoplastic agents
05/2006
05/31/2006EP1660884A2 Crown ether derivatives
05/31/2006EP1660441A2 N-sulfonyl-alpha-amino-acid derivatives
05/30/2006CA2161246C Fullerene derivatives, methods of preparing them and their use
05/24/2006EP1659116A1 Fki-1366 substances and process for producing the same
05/24/2006CN1777619A Compounds with anti-inflammatory activity
05/18/2006DE10208396B4 Dentalmaterialien auf der Basis von substituierten Iminooxadiazindion-Derivaten Dental materials based on substituted iminooxadiazine dione derivatives
05/17/2006EP1349864B1 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases
05/10/2006EP1654241A1 Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof
05/10/2006CN1768745A Agents for improving excretory potency of urinary bladder
05/10/2006CN1255413C (Pyrido/thieno)-[f]-oxazepin-5-one derivatives as AMPA receptor positive regulator
05/04/2006WO2006045587A1 A process for the preparation of [1,4,5]-oxadiazepine derivatives
05/04/2006US20060094718 O-substituted hydroxyaryl derivatives
05/04/2006CA2579742A1 A process for the preparation of [1,4,5]-oxadiazepane derivatives
05/02/2006US7038043 acetylation of indolocarbazoles forming furanosylated indolocarbazole ; reacting a diazo compound with biindole compound
04/2006
04/26/2006EP1153922B1 Heterodiazinone derivatives
04/26/2006CN1764653A FKI-1366 substance and its production
04/20/2006CA2583302A1 Novel oxadiazinone derivatives and use thereof as ppar-alpha modulators
04/18/2006US7030266 Method for producing polyisocyanates
04/18/2006CA2360943C N2-phenylamidine derivatives
04/13/2006WO2006016167A3 17-desmethylrapamycin and analogues thereof, methods for their roduction and their use as immunosupressants, anticancer agents, antifungal agents, etc.
04/13/2006DE102004049291A1 Neue Oxadiazinon-Derivate und ihre Verwendung New Oxadiazinon derivatives and their use
04/13/2006DE102004048871A1 Verfahren zur Herstellung von Iminooxadiazindiongruppen aufweisenden Polyisocyanaten A process for preparing polyisocyanates containing iminooxadiazinedione groups of
04/12/2006EP1645577A1 Process for preparing polyisocyanates having iminoooxadiazinedione groups
04/12/2006EP1404671B1 Macrocycles useful in the treatment of alzheimer's disease
04/12/2006CN1757641A Oligomer with double-azo butter-fly shaped rigid large ring, and its prepn. method
03/2006
03/30/2006US20060069047 Antibiotic conjugates
03/29/2006EP0852495B1 Pharmaceutical compositions containing hydroximic acid derivatives
03/21/2006US7015321 Synthesis of non-symmetrical sulfamides using burgess-type reagents
03/21/2006CA2212466C Calcium specific diaza-18-crown-6-ether chromoionophores
03/16/2006US20060058278 Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease
03/15/2006EP1633771A1 Macrolide-conjugates with anti-inflammatory activity
03/15/2006EP1229977B1 Polyamide-containing ligands covalently bonded to supports, polyamide-containing resins, and methods for removing metals from solutions
03/09/2006WO2006026531A1 Solvent free amorphous rapamycin
03/09/2006CA2578245A1 Solvent free amorphous rapamycin
03/08/2006EP1451167B1 Phenylalkynes
03/02/2006WO2005113542A3 N-cyclic sulfonamido inhibitors of gamma secretase
03/02/2006DE102004040702A1 Verfahren zur Herstellung eines Dioxazin-Derivats A process for the preparation of a dioxazine derivative
03/01/2006EP1414426B1 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases
02/2006
02/23/2006US20060040910 Macrocycles useful in the treatment of Alzheimer's disease
02/22/2006CN1738799A Methods for preparing phenylalkyne derivatives
02/16/2006US20060035884 N-cyclic sulfonamido inhibitors of gamma secretase
02/16/2006CA2575582A1 17-desmethylrapamycin and analogues thereof, methods for their production and their use as immunosupressants, anticancer agents, antifungal agents, etc.
02/14/2006CA2347298C Organic initiators and their use in the polymerization of unsaturated monomers
02/14/2006CA2248598C Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
02/09/2006US20060030553 Cell adhesion inhibitors
02/08/2006EP1623980A1 Preparation of arthropodicidal oxadiazines
02/08/2006EP1622883A2 Compounds, compositions, and methods
02/07/2006CA2268484C Cyclobutyl-aryloxyarylsulfonylamino hydroxamic acid derivatives
02/02/2006WO2006011466A1 5-substituted-2-phenylamino-benzamide as mek inhibitor
02/01/2006CN1239497C Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide
01/2006
01/18/2006EP1616865A1 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
01/11/2006EP1613602A1 Alkylated iminodibenzyls as antioxidants
01/05/2006US20060003978 beta-secretase inhibitors; to reduce A beta peptide formation; to reduce amyloid beta deposits or plaques; 12-[2-(3-Ethyl-benzylamino)-1-hydroxy-ethyl]-16-fluoro-2-oxa-8,11-diaza-bicyclo[12.3.1]octadeca-1(17),14(18),15-triene-7,10-dione
01/03/2006US6982286 Bicarbocyclic hydrazine/hydrazide compounds as inhibitors of semicarbazide-sensitive amine oxidases (SSAO), treat an inflammatory disease or condition, a disease related to carbohydrate metabolism, smooth muscle cell function
12/2005
12/29/2005US20050288359 Agents and methods for the treatment of disorders associated with oxidative stress
12/22/2005WO2005103041A9 Treatment of cns disorders using cns target modulators
12/21/2005EP1466168A4 Ammonium ionophore
12/21/2005CN1232503C Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
12/14/2005EP1604653A1 Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
12/01/2005WO2005113542A2 N-cyclic sulfonamido inhibitors of gamma secretase
12/01/2005CA2567343A1 N-cyclic sulfonamido inhibitors of gamma secretase
11/2005
11/29/2005US6969709 Macrocycles useful in the treatment of Alzheimer's disease
11/24/2005US20050260597 Transfection reagents
11/23/2005EP1598332A2 Indanones and carbamates, and their use in the preparation of anthropodicidal oxadiazines
11/17/2005WO2005107464A2 Compounds and compositions as cathepsin s inhibitors
11/17/2005WO2005016874A3 Crown ether derivatives
11/10/2005US20050250822 Substituted benzanilide compound and noxious organism controlling agent
11/09/2005EP1019389B1 Epothilone derivatives
11/08/2005US6962992 Crown ether derivatives for use in enhancing transfer of indicators into viabile cells
11/03/2005WO2005103041A2 Treatment of cns disorders using cns target modulators
11/03/2005WO2005103019A1 Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors
11/03/2005CA2563826A1 Treatment of cns disorders using cns target modulators
11/03/2005CA2558741A1 Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors
11/02/2005CN1692108A Pesticidal heterocycles
11/01/2005US6960612 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
10/2005
10/20/2005WO2005055715A3 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
10/12/2005EP1583750A2 MACROCYCLIC BETA-SECRETASE INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE
10/12/2005EP1015459B9 Tetrazole-containing rapamycin analogs with shortened half-lives
10/04/2005CA2200823C Isocyanate trimers containing iminooxadiazine dione groups, their preparation and use
09/2005
09/29/2005WO2005090292A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005CA2554609A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/28/2005CN1220690C 5-benzamido-1, 3-dioxide cyclo group compound and preparation process thereof, and use in preparing protein kinase C inhibito medicine
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/22/2005WO2005087236A1 Novel m3 muscarinic acetylcholine receptor antagonists
09/22/2005WO2005068445A3 Pesticidal heterocyclic dihaloallyl compounds
09/14/2005EP1499609A4 Pesticidal heterocycles
09/14/2005CN1668575A Tgents and methods for the treatment of disorders associated with oxidative stress
09/13/2005US6942966 Methods for processing chemical compounds having reactive functional groups
09/09/2005WO2005082870A1 Abc transporter inhibitor
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 24